RT Book, Section A1 Douglas, Vanja C. A1 Aminoff, Michael J. A2 Papadakis, Maxine A. A2 McPhee, Stephen J. A2 Rabow, Michael W. A2 McQuaid, Kenneth R. SR Print(0) ID 1184185022 T1 Degenerative Motor Neuron Diseases T2 Current Medical Diagnosis & Treatment 2022 YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781264269389 LK accessmedicine.mhmedical.com/content.aspx?aid=1184185022 RD 2024/03/28 AB Key Clinical Updates in Degenerative Motor Neuron DiseasesRisdiplam (5 mg orally daily for patients 2 years of age and older weighing more than 20 kg) is approved for use in infants and adults.